Loading...
•
Jun 30, 2020
Prothena Q2 2020 Earnings Report
Reported financial results for the second quarter and first six months of 2020.
Key Takeaways
Prothena reported a net loss of $26.3 million for the second quarter of 2020, compared to a net loss of $15.8 million for the same period in 2019. Total revenue was $0.2 million, primarily from the collaboration with Roche. As of June 30, 2020, Prothena had $336.6 million in cash, cash equivalents and restricted cash.
Net loss of $26.3 million, or $0.66 per share, compared to a net loss of $15.8 million, or $0.40 per share, for the second quarter of 2019.
Total revenue of $0.2 million compared to $0.2 million for the second quarter of 2019.
Research and development expenses totaled $17.3 million, compared to $9.6 million for the second quarter of 2019.
Cash, cash equivalents and restricted cash totaled $336.6 million as of June 30, 2020.
Revenue by Segment
Forward Guidance
The Company continues to expect its full year 2020 net cash burn from operating and investing activities to be $75-$85 million, and expects to end the year with approximately $299 million in cash, cash equivalents and restricted cash (midpoint).
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...